MANE +4.4% premarket after said its oral, extended-release formulation of minoxidil induced hair growth in women with mild-to-moderate Patte

MANE +4.4% premarket after said its oral, extended-release formulation of minoxidil induced hair growth in women with mild-to-moderate Pattern hair loss, achieving the goal of a single-arm mid Stage study.